Understanding a new immune control for gut inflammation
Studies of a new checkpoint regulator in the control of intestinal inflammation
This research explores how a newly discovered protein helps regulate our body's natural defenses to prevent inflammation in the gut.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Methodist Hospital Research Institute NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11096060 on NIH RePORTER |
What this research studies
Our bodies have a natural defense system, called the innate immune system, that protects us from harmful germs. While fighting infections, this system needs careful control to avoid causing too much inflammation in our tissues, especially in the gut. This project focuses on a specific protein, TRIM29, found in the cells lining the intestine, which we believe acts as a key regulator to calm down immune responses. By understanding how TRIM29 works, we hope to learn more about how to prevent and treat conditions like colitis and other inflammatory bowel diseases.
Who could benefit from this research
Good fit: Patients with conditions involving intestinal inflammation, such as colitis or inflammatory bowel disease, could potentially benefit from future treatments developed from this research.
Not a fit: Patients without conditions related to intestinal inflammation or immune system dysregulation may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new ways to manage and treat chronic intestinal inflammation and related autoimmune conditions.
How similar studies have performed: This research builds upon recent discoveries about the role of specific proteins in immune regulation, suggesting a novel approach within an established field.
Where this research is happening
Houston, United States
- Methodist Hospital Research Institute — Houston, United States (Active)
Researchers
- Principal investigator: Zhang, Zhiqiang — Methodist Hospital Research Institute
- Study coordinator: Zhang, Zhiqiang
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.